Bank of New York Mellon’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-24,584
| Closed | -$77K | – | 4465 |
|
|
2017
Q3 | $77K | Buy |
24,584
+31
| +0.1% | +$97 | ﹤0.01% | 4040 |
|
|
2017
Q2 | $99K | Sell |
24,553
-7,157
| -23% | -$28.9K | ﹤0.01% | 4029 |
|
|
2017
Q1 | $118K | Buy |
31,710
+6,907
| +28% | +$25.7K | ﹤0.01% | 3985 |
|
|
2016
Q4 | $48K | Buy |
24,803
+20,970
| +547% | +$40.6K | ﹤0.01% | 4135 |
|
|
2016
Q3 | $24K | Sell |
3,833
-664
| -15% | -$4.16K | ﹤0.01% | 4208 |
|
|
2016
Q2 | $20K | Sell |
4,497
-9,620
| -68% | -$42.8K | ﹤0.01% | 4266 |
|
|
2016
Q1 | $148K | Sell |
14,117
-3,727
| -21% | -$39.1K | ﹤0.01% | 3876 |
|
|
2015
Q4 | $526K | Buy |
17,844
+2,233
| +14% | +$65.8K | ﹤0.01% | 3487 |
|
|
2015
Q3 | $493K | Sell |
15,611
-256
| -2% | -$8.09K | ﹤0.01% | 3559 |
|
|
2015
Q2 | $939K | Sell |
15,867
-6,939
| -30% | -$411K | ﹤0.01% | 3374 |
|
|
2015
Q1 | $2.44M | Buy |
22,806
+676
| +3% | +$72.3K | ﹤0.01% | 2727 |
|
|
2014
Q4 | $2.08M | Buy |
22,130
+6,675
| +43% | +$627K | ﹤0.01% | 2856 |
|
|
2014
Q3 | $1.19M | Buy |
15,455
+3,663
| +31% | +$281K | ﹤0.01% | 3190 |
|
|
2014
Q2 | $1.06M | Buy |
11,792
+5,606
| +91% | +$503K | ﹤0.01% | 3279 |
|
|
2014
Q1 | $331K | Sell |
6,186
-31
| -0.5% | -$1.66K | ﹤0.01% | 3698 |
|
|
2013
Q4 | $157K | Buy |
6,217
+253
| +4% | +$6.39K | ﹤0.01% | 3871 |
|
|
2013
Q3 | $162K | Buy |
5,964
+1,278
| +27% | +$34.7K | ﹤0.01% | 3812 |
|
|
2013
Q2 | $169K | Buy |
+4,686
| New | +$169K | ﹤0.01% | 3791 |
|